HR 3520 · 116th Congress · Health

Stem Cell Therapeutic and Research Reauthorization Act of 2019

Introduced 2019-06-26· Sponsored by Rep. Smith, Christopher H. [R-NJ-4]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2019-06-27)

Plain Language Summary

[AI summary unavailable — showing source text] Stem Cell Therapeutic and Research Reauthorization Act of 2019 This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (3)

1 Democrat2 Republicans